Samer Choucair: The Global Shift Toward Natural Ingredients Is Reshaping the Future of the Food and Beverage Industry
Entrepreneur Samer Choucair said the findings of a long-term scientific study linking high consumption of several artificial sweeteners to an accelerated decline in cognitive abilities represent more than a healthcare development. They have become an important investment signal that may prompt institutional investors to reassess their positions across the food and beverage sector.
Choucair explained that the study, published in the journal Neurology, followed more than 12,000 participants over eight years and found that those with the highest consumption of artificial sweeteners experienced a 62% faster decline in overall cognitive ability.
This was equivalent to approximately 1.6 additional years of brain aging, with the association appearing particularly pronounced among people under the age of 60 and those with diabetes.
Samer Choucair added that these findings could lead to a repricing of risk across food-industry value chains while expanding opportunities for clean-label products and natural alternatives, particularly as global rates of aging and diabetes continue to rise.
Health and regulatory pressures accelerate the transition
Samer Choucair noted that artificial sweeteners such as aspartame, saccharin, acesulfame potassium, erythritol, sorbitol, and xylitol have become common ingredients in low-calorie beverages, milk products, yogurt, and ultra-processed foods.
However, repeated statistical associations between high consumption of these sweeteners and accelerated cognitive decline, even after adjusting for factors such as age, high blood pressure, and cardiovascular disease, have raised growing questions about the long-term sustainability of this model.
Choucair added that regulatory and consumer pressure on artificial ingredients continues to increase, while consumers—particularly those in the most economically active age groups—are showing a stronger preference for products made with natural and clearly disclosed ingredients.
This supports rising demand for alternatives such as stevia, fruit extracts, and other natural sweeteners.
He noted that the trend appears particularly pronounced in emerging markets, where high diabetes rates coincide with the expansion of the middle class.
Entrepreneur Samer Choucair emphasized that scientific studies of this kind do not change consumer behavior overnight. They do, however, reprice long-term risks within consumer-company portfolios and encourage institutional capital to favor business models with lower regulatory and reputational exposure.
Direct implications for food and beverage companies
Samer Choucair said companies heavily dependent on artificial sweeteners may face growing pressure on profit margins because of product-reformulation costs, increased expenditure on defensive marketing campaigns, or slower growth in low-calorie product categories.
He explained that global companies operating in carbonated beverages and processed foods may have to accelerate their transition toward natural sweeteners or blends combining natural and artificial alternatives.
This could require additional capital expenditure and affect short-term earnings expectations.
Choucair said investment opportunities may expand for companies specializing in natural sweeteners and clean extraction technologies, as well as businesses involved in nutritional supplements associated with brain health and healthy aging.
He noted that the natural-sweetener market continues to grow as demand for clean-label products rises, potentially encouraging mergers and acquisitions by major companies seeking to secure their supply chains.
He added that financial markets may increasingly favor consumer-goods companies with stronger environmental and social governance practices, alongside greater scrutiny of disclosures relating to the health effects of ingredients.
Investment opportunities in Saudi Arabia and the Gulf
Entrepreneur Samer Choucair emphasized that this issue carries particular importance for Gulf countries because of elevated rates of diabetes and obesity.
Saudi Arabia is working under the objectives of Vision 2030 to reduce obesity and diabetes rates and has already introduced measures such as taxes on sugary beverages and requirements for companies to display calorie information, encouraging businesses to reformulate their products.
Choucair added that these developments create new investment opportunities in the local production of natural alternatives and in supply chains connected to the digital economy and preventive healthcare.
Sovereign investment funds and the private sector may view this transition as an opportunity to strengthen food security and support economic diversification while reducing dependence on imported ultra-processed products.
“Investing in more sustainable food solutions in markets such as Saudi Arabia and the wider Gulf has become part of a broader capital-allocation strategy that brings together public-health objectives and economic-diversification goals,” Samer Choucair said.
“It is no longer merely a response to changing consumer trends.”
The reassessment of investment portfolios
Samer Choucair explained that pension funds, sovereign wealth funds, and private investment firms may need to reconsider the scale of their exposure to the consumer-staples sector.
He expects portfolios to increase their allocation to companies with strong natural-alternative product lines or advanced research investments in functional foods.
Choucair added that venture capital investors may find promising opportunities in startups developing new sweetening technologies or digital platforms connecting consumers with data-supported healthy products.
Fixed-income markets, meanwhile, may apply stricter credit-risk pricing to companies facing high product-reformulation costs or increasing regulatory exposure.
He emphasized that institutional investors are no longer focused solely on revenue growth. They are paying greater attention to whether a business model can adapt to scientific and regulatory change.
Companies that disregard these signals may face a higher cost of capital over the coming years.
The outlook for the next phase
Concluding his remarks, Samer Choucair said markets will closely monitor the findings of subsequent studies and confirmatory research over the next 12 months, alongside the positions adopted by regulators in major markets.
Over a three-to-five-year horizon, major companies are likely to accelerate the transformation of their product portfolios, increasing the share of natural sweeteners within their overall product mix.
Over the longer term, spanning five to ten years, the trend could reshape global food supply chains and support the growth of nutritional supplements, brain-health products, and healthy-aging solutions, particularly in economies facing increasing demographic pressures.
“Investors who incorporate these scientific developments into their valuation models at an early stage will be best positioned to benefit from the coming wave of capital reallocation,” entrepreneur Samer Choucair concluded.
“Investment flows ultimately move toward business models capable of adapting to accumulated scientific knowledge, rather than those built on consumer assumptions that reality has already overtaken.”